150 related articles for article (PubMed ID: 8308458)
1. Dopamine is taken up from the circulation by, and released from, local noradrenergic varicose axon terminals in zona glomerulosa of the rat: a neurochemical and immunocytochemical study.
Vizi ES; Tóth IE; Orsó E; Szalay KS; Szabó D; Baranyi M; Vinson GP
J Endocrinol; 1993 Nov; 139(2):213-26. PubMed ID: 8308458
[TBL] [Abstract][Full Text] [Related]
2. Catecholamines released from local adrenergic axon terminals are possibly involved in fine tuning of steroid secretion from zona glomerulosa cells: functional and morphological evidence.
Vizi ES; Tóth IE; Szalay KS; Windisch K; Orsó E; Szabó D; Vinson GP
J Endocrinol; 1992 Dec; 135(3):551-61. PubMed ID: 1487708
[TBL] [Abstract][Full Text] [Related]
3. ATP and [3H]noradrenaline release and the presence of ecto-Ca(2+)-ATPases in the capsule-glomerulosa fraction of the rat adrenal gland.
Jurányi Z; Orsó E; Jánossy A; Szalay KS; Sperlágh B; Windisch K; Vinson GP; Vizi ES
J Endocrinol; 1997 Apr; 153(1):105-14. PubMed ID: 9135575
[TBL] [Abstract][Full Text] [Related]
4. Dopamine, as well as norepinephrine, is a link between noradrenergic nerve terminals and splenocytes.
Bencsics A; Sershen H; Baranyi M; Hashim A; Lajtha A; Vizi ES
Brain Res; 1997 Jul; 761(2):236-43. PubMed ID: 9252021
[TBL] [Abstract][Full Text] [Related]
5. Cholinergic regulation of the rat adrenal zona glomerulosa.
Jánossy A; Orsó E; Szalay KS; Jurányi Z; Beck M; Vizi ES; Vinson GP
J Endocrinol; 1998 May; 157(2):305-15. PubMed ID: 9659294
[TBL] [Abstract][Full Text] [Related]
6. Local non-synaptic modulation of aldosterone production by catecholamines and ATP in rat: implications for a direct neuronal fine tuning.
Szalay KS; Orsó E; Jurányi Z; Vinson GP; Vizi ES
Horm Metab Res; 1998; 30(6-7):323-8. PubMed ID: 9694557
[TBL] [Abstract][Full Text] [Related]
7. Neurochemical, electrophysiological and immunocytochemical evidence for a noradrenergic link between the sympathetic nervous system and thymocytes.
Vizi ES; Orsó E; Osipenko ON; Haskó G; Elenkov IJ
Neuroscience; 1995 Oct; 68(4):1263-76. PubMed ID: 8544999
[TBL] [Abstract][Full Text] [Related]
8. Local production and action of adrenomedullin in the rat adrenal zona glomerulosa.
Kapas S; Martínez A; Cuttitta F; Hinson JP
J Endocrinol; 1998 Mar; 156(3):477-84. PubMed ID: 9582504
[TBL] [Abstract][Full Text] [Related]
9. Noradrenergic terminals are the primary source of α
Devoto P; Flore G; Saba P; Scheggi S; Mulas G; Gambarana C; Spiga S; Gessa GL
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Mar; 90():97-103. PubMed ID: 30472147
[TBL] [Abstract][Full Text] [Related]
10. Brain tissue transplanted to the anterior chamber of the eye. 4. Drug-modulated transmitter release in central monoamine nerve terminals lacking normal postsynaptic receptors.
Seiger A; Olson L; Farnebo LO
Cell Tissue Res; 1976 Jan; 165(2):157-70. PubMed ID: 174817
[TBL] [Abstract][Full Text] [Related]
11. Dopamine increases interleukin 6 release and inhibits tumor necrosis factor release from rat adrenal zona glomerulosa cells in vitro.
Ritchie PK; Ashby M; Knight HH; Judd AM
Eur J Endocrinol; 1996 May; 134(5):610-6. PubMed ID: 8664982
[TBL] [Abstract][Full Text] [Related]
12. Dopamine in rat adrenal glomerulosa.
Pratt JH; Turner DA; Bowsher RR; Henry DP
Life Sci; 1987 Mar; 40(9):811-6. PubMed ID: 3821378
[TBL] [Abstract][Full Text] [Related]
13. Release and turnover of noradrenaline in isolated median eminence: lack of negative feedback modulation.
Vizi ES; Harsing LG; Zimanvi I; Gaal G
Neuroscience; 1985 Dec; 16(4):907-16. PubMed ID: 3005913
[TBL] [Abstract][Full Text] [Related]
14. Dual effects of dopamine in rat adrenal glomerulosa cells.
Gallo-Payet N; Chouinard L; Balestre MN; Guillon G
Biochem Biophys Res Commun; 1990 Nov; 172(3):1100-8. PubMed ID: 2173914
[TBL] [Abstract][Full Text] [Related]
15. Disulfiram stimulates dopamine release from noradrenergic terminals and potentiates cocaine-induced dopamine release in the prefrontal cortex.
Devoto P; Flore G; Saba P; Cadeddu R; Gessa GL
Psychopharmacology (Berl); 2012 Feb; 219(4):1153-64. PubMed ID: 21863234
[TBL] [Abstract][Full Text] [Related]
16. Evidence for co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex.
Devoto P; Flore G; Pani L; Gessa GL
Mol Psychiatry; 2001 Nov; 6(6):657-64. PubMed ID: 11673793
[TBL] [Abstract][Full Text] [Related]
17. Differential sensitivity to hydrogen peroxide of dopaminergic and noradrenergic neurotransmission in rat brain slices.
Langeveld CH; Schepens E; Stoof JC; Bast A; Drukarch B
Free Radic Biol Med; 1995 Aug; 19(2):209-17. PubMed ID: 7649492
[TBL] [Abstract][Full Text] [Related]
18. Release of [3H]-noradrenaline from rat hippocampal synaptosomes by nicotine: mediation by different nicotinic receptor subtypes from striatal [3H]-dopamine release.
Clarke PB; Reuben M
Br J Pharmacol; 1996 Feb; 117(4):595-606. PubMed ID: 8646402
[TBL] [Abstract][Full Text] [Related]
19. Changes in sensitivity of release modulating dopamine autoreceptors after chronic treatment with haloperidol.
Nowak JZ; Arbilla S; Galzin AM; Langer SZ
J Pharmacol Exp Ther; 1983 Aug; 226(2):558-64. PubMed ID: 6875865
[TBL] [Abstract][Full Text] [Related]
20. Receptor mediated presynaptic modulation of the release of noradrenaline in human papillary muscle.
Matkó I; Fehér E; Vizi ES
Cardiovasc Res; 1994 May; 28(5):700-4. PubMed ID: 7912992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
